Ipsen (IPSEY) EV-to-EBITDA : 8.18 (As of Dec. 11, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Ipsen EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ipsen's enterprise value is $9,381 Mil. Ipsen's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $1,147 Mil. Therefore, Ipsen's EV-to-EBITDA for today is 8.18.

The historical rank and industry rank for Ipsen's EV-to-EBITDA or its related term are showing as below:

IPSEY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.22 Med: 14.22 Max: 54.51
Current: 8.18

During the past 13 years, the highest EV-to-EBITDA of Ipsen was 54.51. The lowest was 6.22. And the median was 14.22.

IPSEY's EV-to-EBITDA is ranked better than
73.4% of 718 companies
in the Drug Manufacturers industry
Industry Median: 14.23 vs IPSEY: 8.18

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-11), Ipsen's stock price is $29.064. Ipsen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.215. Therefore, Ipsen's PE Ratio (TTM) for today is 13.12.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Ipsen EV-to-EBITDA Historical Data

The historical data trend for Ipsen's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen EV-to-EBITDA Chart

Ipsen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

46.72

7.30

6.16

7.22

9.81

Ipsen Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EV-to-EBITDA	Get a 7-Day Free Trial															-	7.22	-	9.81	-

Competitive Comparison of Ipsen's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipsen's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipsen's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ipsen's EV-to-EBITDA falls into.

Ipsen EV-to-EBITDA Calculation

Ipsen's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	9380.514	/	1146.974
	=	8.18

Ipsen's current Enterprise Value is $9,381 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ipsen's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $1,147 Mil.

Ipsen (OTCPK:IPSEY) EV-to-EBITDA Explanation

Ipsen's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	29.064	/	2.215
	=	13.12

Ipsen's share price for today is $29.064.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ipsen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $2.215.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Ipsen EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ipsen's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEY) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

IPSEF:USA IPNp:UK 0MH6:UK IPN:France I7G:Germany

Address

65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.